organophosphonates has been researched along with cocaine in 8 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (cocaine) | Trials (cocaine) | Recent Studies (post-2010) (cocaine) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 32,461 | 1,096 | 9,400 |
| Protein | Taxonomy | organophosphonates (IC50) | cocaine (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.338 | |
| Fatty acid-binding protein, heart | Homo sapiens (human) | 0.367 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0855 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0855 | |
| D | Rattus norvegicus (Norway rat) | 5.7544 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.2861 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.4321 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0855 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.5442 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.8885 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.3796 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 5.541 | |
| Sodium-dependent dopamine transporter | Mus musculus (house mouse) | 0.2 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.05 | |
| Transporter | Rattus norvegicus (Norway rat) | 3.2277 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkman, CE; Cashman, JR; Underiner, GE | 1 |
| Brocklehurst, K; Gallacher, G; Hagi-Pavli, EP; Ostler, EL; Simms, CS | 1 |
| Andrews, M; Brebner, K; Froestl, W; Phelan, R; Roberts, DC | 1 |
| Brebner, K; Roberts, DC | 1 |
| Ashley, JA; Hoffman, TZ; Janda, KD; Matsushita, M; Wirsching, P; Zhou, B | 1 |
| Dobrovitsky, V; Duarte, A; Froestl, W; Pimentel, P; Stellar, JR; Trzcińska, M | 1 |
| He, YY; Li, FQ; Li, YQ; Lu, L; Sacktor, TC; Shaham, Y; Xu, CM; Xue, LF; Xue, YX | 1 |
| Davis, FA; Edupuganti, R | 1 |
1 review(s) available for organophosphonates and cocaine
| Article | Year |
|---|---|
GABA modulation of cocaine self-administration.
Topics: Animals; Baclofen; Cocaine; Conditioning, Psychological; gamma-Aminobutyric Acid; Organophosphonates; Phosphinic Acids; Reinforcement, Psychology; Self Administration | 2000 |
7 other study(ies) available for organophosphonates and cocaine
| Article | Year |
|---|---|
Stereoselective inhibition of human butyrylcholinesterase by phosphonothiolate analogs of (+)- and (-)-cocaine.
Topics: Butyrylcholinesterase; Cholinesterase Inhibitors; Cocaine; Humans; Organophosphonates; Stereoisomerism | 1997 |
Synthesis of a transition state analogue for the hydrolysis of cocaine: assistance to phosphonylation of a 3beta-hydroxytropane by a neighbouring amide group.
Topics: Amides; Cocaine; Hydrolysis; Organophosphonates; Time Factors; Tropanes | 1999 |
The GABA(B) agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure.
Topics: Animals; Behavior, Addictive; Cocaine; Dopamine Uptake Inhibitors; Eating; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Male; Organophosphonates; Phosphinic Acids; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration | 1999 |
Cocaine catalytic antibodies: the primary importance of linker effects.
Topics: Animals; Antibodies, Catalytic; Antibodies, Monoclonal; Cocaine; Cocaine-Related Disorders; Drug Design; Haptens; Hydrolysis; Kinetics; Mice; Organophosphonates; Structure-Activity Relationship | 2001 |
CGP 44532, a GABAB receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward.
Topics: Animals; Behavior, Addictive; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Male; Organophosphonates; Phosphinic Acids; Rats; Rats, Sprague-Dawley; Reaction Time; Reward | 2002 |
Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug reward memory.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Endocytosis; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Male; Memory; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Nucleus Accumbens; Oligopeptides; Organophosphonates; Piperazines; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Reward; Substance Withdrawal Syndrome; Time Factors; Valine | 2011 |
Synthesis and applications of masked oxo-sulfinamides in asymmetric synthesis.
Topics: Amides; Amines; Amino Acids; Amino Alcohols; beta-Lactams; Chemistry Techniques, Synthetic; Cocaine; Heterocyclic Compounds; Imines; Organophosphonates; Pipecolic Acids; Proline; Pyrrolidines; Sulfonium Compounds; Tropanes | 2012 |